PURE BIOLOGICS SPOLKA AKCYJNAPURE BIOLOGICS SPOLKA AKCYJNAPURE BIOLOGICS SPOLKA AKCYJNA

PURE BIOLOGICS SPOLKA AKCYJNA

No trades
See on Supercharts
Market capitalization
‪14.38 M‬EUR
‪−8.20 M‬EUR
‪21.83 K‬EUR
‪3.27 M‬
Beta (1Y)
−2.41
Employees (FY)
51
Change (1Y)
−45 −46.88%
Revenue / Employee (1Y)
427.98EUR
Net income / Employee (1Y)
‪−160.80 K‬EUR

About PURE


CEO
Filip Jan Jelen
Headquarters
Wroclaw
Founded
2010
ISIN
PLPRBLG00010
FIGI
BBG00MTKPWZ9
Pure Biologics SA engages in the research and development of biological drug and non-systemic therapies. It focuses on immuno-oncology, autoimmunology, and rare neurological diseases. The company was founded by Filip Jan Jelen, Maciej Piotr Mazurek, Piotr Jan Jakimowicz, Jacek Józef Otlewski, and Andrzej Jan Trznade and in 2010 and is headquartered in Wroclaw, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PQB is 3.37 EUR — it has decreased by −11.10% in the past 24 hours. Watch PURE BIOLOGICS SPOLKA AKCYJNA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PURE BIOLOGICS SPOLKA AKCYJNA stocks are traded under the ticker PQB.
PQB stock has risen by 7.00% compared to the previous week, the month change is a −7.43% fall, over the last year PURE BIOLOGICS SPOLKA AKCYJNA has showed a 117.38% increase.
PQB reached its all-time high on Aug 7, 2020 with the price of 29.49 EUR, and its all-time low was 1.27 EUR and was reached on Dec 21, 2023. View more price dynamics on PQB chart.
See other stocks reaching their highest and lowest prices.
PQB stock is 12.48% volatile and has beta coefficient of −2.41. Track PURE BIOLOGICS SPOLKA AKCYJNA stock price on the chart and check out the list of the most volatile stocks — is PURE BIOLOGICS SPOLKA AKCYJNA there?
Today PURE BIOLOGICS SPOLKA AKCYJNA has the market capitalization of ‪14.38 M‬, it has increased by 0.91% over the last week.
Yes, you can track PURE BIOLOGICS SPOLKA AKCYJNA financials in yearly and quarterly reports right on TradingView.
PQB net income for the last quarter is ‪−190.34 K‬ EUR, while the quarter before that showed ‪−1.16 M‬ EUR of net income which accounts for 83.54% change. Track more PURE BIOLOGICS SPOLKA AKCYJNA financial stats to get the full picture.
No, PQB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 1, 2025, the company has 51.00 employees. See our rating of the largest employees — is PURE BIOLOGICS SPOLKA AKCYJNA on this list?
Like other stocks, PQB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURE BIOLOGICS SPOLKA AKCYJNA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PURE BIOLOGICS SPOLKA AKCYJNA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PURE BIOLOGICS SPOLKA AKCYJNA stock shows the sell signal. See more of PURE BIOLOGICS SPOLKA AKCYJNA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.